跳至主要内容
临床试验/JPRN-UMIN000002959
JPRN-UMIN000002959已完成4 期

Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound - The PRECISE-IVUS trial

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University0 个研究点目标入组 300 人开始时间: 2010年1月6日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Familial hypercholesterolemia - Being treated with Zetia (Ezetimibe) - Being treated with Fibrates - Renal insufficiency (serum creatinine >= 2.0 mg/dl) - Altered hepatic function (serum aspartate aminotransferase or alanine aminotransferase >= 3-folds of standard value in each institute) - Undergoing hemodialysis or peritoneal dialysis - Allergic to Lipitor and/or Zetia - Severe underlying disease - Lack of decision-making capacity - Recognized as inadequate by attending doctor

研究者

发起方
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

相似试验